Table 2.
The clinical characteristics were analyzed
| Characteristics | TIPE2 | Positive rate (%) | P value | |
|---|---|---|---|---|
| Positive | Negative | |||
| Gender | ||||
| Male | 7 | 40 | 14.89 | 0.493 |
| Female | 5 | 16 | 23.81 | |
| Age (yr) | ||||
| 60 yr. or younger | 3 | 16 | 15.79 | 1.000 |
| Over 60 yr | 9 | 40 | 18.37 | |
| Differentiation | ||||
| Moderate | 9 | 22 | 29.03 | 0.024 |
| Poor | 3 | 34 | 8.11 | |
| Stage | ||||
| I + II | 10 | 23 | 30.30 | 0.008 |
| III + IV | 2 | 33 | 5.71 | |
| Lymph nodes involvement | ||||
| Yes | 2 | 42 | 4.55 | 0.000 |
| No | 10 | 14 | 41.67 | |
TIPE2 was closely associated with tumor differentiation, stages and lymph node metastasis. P values with italics (P < 0.05) represented significant differences